Published May 23, 2024
| Version v1
Journal article
Open
Drug interaction detection and glycemic control – telepharmacy's role in diabetes management: before-after study
Authors/Creators
- 1. Universitas Padjadjaran, Sumedang, Indonesia|Bhakti Kencana University, Bandung, Indonesia
- 2. Universitas Padjadjaran, Sumedang, Indonesia
- 3. The Indonesian Food and Drug Authority, Jakarta, Indonesia|General of Pharmacy and Medical Devices of Health of the Republic of Indonesia, Jakarta, Indonesia
Description
Introduction: Diabetes management faces intertwined challenges like polypharmacy and adherence complexities, hindering effective care delivery. Telepharmacy emerges as a promising solution, revolutionizing diabetes care by enhancing pharmacists' pivotal role. However, a tailored model for Indonesia is still lacking.
Purpose: This study aimed to assess the potential effectiveness of a telepharmacy application in improving the detection of drug-drug interactions and glycemic control.
Methods: We conducted an observational before-and-after study among type 2 diabetic patients in Indonesia.
Results: We noted a significant surge in detected drug interactions. Patients counseled through telepharmacy had 3.653 times higher likelihood of achieving good glycemic control.
Conclusion: The study underscores the positive impact of telepharmacy on drug interaction detection and glycemic control among Indonesian diabetics.
Files
PHAR_article_123313.pdf
Files
(370.3 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:51c19b30b7e1f1dd4808196ff8a6a9c0
|
273.7 kB | Preview Download |
|
md5:0e902198a00d37eabec192f40e0f5ff1
|
96.6 kB | Preview Download |
Additional details
References
- Alkaff F, Sukmajaya W, Intan R, Salamah S (2020) Effectivity of Indonesia Chronic Disease Management Program (PROLANIS) to control hypertension and its comorbidities at primary health care: Effectivity of PROLANIS to control hypertension. Open Access Macedonian Journal of Medical Sciences 8: 224–227. https://doi.org/10.3889/oamjms.2020.4583
- Alkaff FF, Illavi F, Salamah S, Setiyawati W, Ramadhani R, Purwantini E, Tahapary DL (2021) The impact of the Indonesian Chronic Disease Management Program (PROLANIS) on metabolic control and renal function of Type 2 diabetes mellitus patients in primary care setting. Journal of Primary Care & Community Health 12: 1–10. https://doi.org/10.1177/2150132720984409
- Alwhaibi M, Balkhi B, Alhawassi TM, Alkofide H, Alduhaim N, Alabdulali R, Drweesh H, Sambamoorthi U (2018) Polypharmacy among patients with diabetes: a cross-sectional retrospective study in a tertiary hospital in Saudi Arabia. BMJ Open 8: 1–8. https://doi.org/10.1136/bmjopen-2017-020852
- American Diabetes Association (2021) 6. Glycemic Targets: Standards of Medical Care in Diabetes-2021. Diabetes Care 44: S73–S84. https://doi.org/10.2337/dc21-S006
- Anjana RM, Pradeepa R, Deepa M, Jebarani S, Venkatesan U, Parvathi SJ, Balasubramanyam M, Radha V, Poongothai S, Sudha V, Shanthi Rani CS, Ranjani H, Amutha A, Manickam N, Unnikrishnan R, Mohan V (2020) Acceptability and Utilization of Newer Technologies and Effects on Glycemic Control in Type 2 Diabetes: Lessons Learned from Lockdown. Diabetes Technology & Therapeutics 22: 527–534. https://doi.org/10.1089/dia.2020.0240
- Baldoni S, Amenta F, Ricci G (2019) Telepharmacy Services: Present Status and Future Perspectives: A Review. Medicina 55: 1–12. https://doi.org/10.3390/medicina55070327
- Bui DHT, Nguyen BX, Truong DC, Meyrowitsch DW, Søndergaard J, Gammeltoft T, Bygbjerg IC, Jannie N (2021) Polypharmacy among people living with type 2 diabetes mellitus in rural communes in Vietnam. PLoS ONE 16: e0249849. https://doi.org/10.1371/journal.pone.0249849
- Campbell RK (2002) Role of the pharmacist in diabetes management. American Journal of Health-System Pharmacy 59: S18–S21. https://doi.org/10.1093/ajhp/59.suppl_9.S18
- Cao DX, Tran RJC, Yamzon J, Stewart TL, Hernandez EA (2022) Effectiveness of telepharmacy diabetes services: A systematic review and meta-analysis. American Journal of Health-System Pharmacy 79: 860–872. https://doi.org/10.1093/ajhp/zxac070
- Crossen SS, Bruggeman BS, Haller MJ, Raymond JK (2022) Challenges and opportunities in using telehealth for diabetes care. Diabetes Spectrum: A Publication of the American Diabetes Association 35: 33–42. https://doi.org/10.2337/dsi21-0018
- Cuschieri S (2019) The STROBE guidelines. Saudi Journal of Anaesthesia 13: S31–S34. https://doi.org/10.4103/sja.SJA_543_18
- Dong Y, Peng C-YJ (2013) Principled missing data methods for researchers. SpringerPlus 2: 1–17. https://doi.org/10.1186/2193-1801-2-222
- Duruturk N, Özköslü MA (2019) Effect of tele-rehabilitation on glucose control, exercise capacity, physical fitness, muscle strength and psychosocial status in patients with type 2 diabetes: A double blind randomized controlled trial. Primary Care Diabetes 13: 542–548. https://doi.org/10.1016/j.pcd.2019.03.007
- von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP (2007) The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Annals of Internal Medicine 147: 573–577. https://doi.org/10.7326/0003-4819-147-8-200710160-00010
- Eshbair A, El-Dahiyat F, Jamshed S (2022) The role of pharmacists in diabetes management in Abu Dhabi, United Arab Emirates. International Journal of Diabetes in Developing Countries 42: 474–481. https://doi.org/10.1007/s13410-021-00986-w
- Feng Y-H, Zhang S-W, Shi J-Y (2020) DPDDI: a deep predictor for drug-drug interactions. BMC Bioinformatics 21: 1–15. https://doi.org/10.1186/s12859-020-03724-x
- Fukuda H, Mizobe M (2017) Impact of nonadherence on complication risks and healthcare costs in patients newly-diagnosed with diabetes. Diabetes Research and Clinical Practice 123: 55–62. https://doi.org/10.1016/j.diabres.2016.11.007
- Gast A, Mathes T (2019) Medication adherence influencing factors-an (updated) overview of systematic reviews. Systematic Reviews 8: 1–7. https://doi.org/10.1186/s13643-019-1014-8
- Hamasaki H (2022) Patient Satisfaction with Telemedicine in Adults with Diabetes: A Systematic Review. Healthcare 10: 1677. https://doi.org/10.3390/healthcare10091677
- Han K, Cao P, Wang Y, Xie F, Ma J, Yu M, Wang J, Xu Y, Zhang Y, Wan J (2022) A review of approaches for predicting drug-drug interactions based on machine learning. Frontiers in Pharmacology 12: 1–10. https://doi.org/10.3389/fphar.2021.814858
- Hickman E, Gillies C, Khunti K, Seidu S (2023) Deprescribing, Polypharmacy and Prescribing Cascades in Older People with Type 2 Diabetes: A Focused Review. Journal of the Indian Institute of Science 103: 191–204. https://doi.org/10.1007/s41745-022-00352-7
- Iftinan GN, Wathoni N, Lestari K (2021) Telepharmacy: A potential alternative approach for diabetic patients during the COVID-19 pandemic. Journal of Multidisciplinary Healthcare 14: 2261–2273. https://doi.org/10.2147/JMDH.S325645
- Knezevich JT, Donihi AC, Drincic AT (2022) Pharmacist Role in Providing Inpatient Diabetes Management. Current Diabetes Reports 22: 441–449. https://doi.org/10.1007/s11892-022-01487-8
- Koto R, Nakajima A, Miwa T, Sugimoto K (2023) Multimorbidity, Polypharmacy, Severe Hypoglycemia, and Glycemic Control in Patients Using Glucose-Lowering Drugs for Type 2 Diabetes: A Retrospective Cohort Study Using Health Insurance Claims in Japan. Diabetes Therapy 14: 1175–1192. https://doi.org/10.1007/s13300-023-01421-5
- Lee DSU, Lee H (2022) Adherence and persistence rates of major antidiabetic medications: a review. Diabetology & Metabolic Syndrome 14: 1–23. https://doi.org/10.1186/s13098-022-00785-1
- Lisni I, Lestari K, Andalusia L, Rahmawati D (2023) Utilization of Expert Systems as a Source of Information in Detecting Drug Interactions in the Treatment of Diabetes Mellitus Patients: A Systematic Literature Review. Research Journal of Pharmacy and Technology, 328–332. https://doi.org/10.52711/0974-360X.2023.00058
- J ALHarbi T, Rsheed AMB, Alrasheedy AA, ALMadani W, ALJuraisi F, AlOtaibi AF, AlHarbi M, AlAbood AF, Alshaikh AAI (2023) The impact of telemedicine on patients with uncontrolled type 2 diabetes mellitus during the COVID-19 pandemic in Saudi Arabia: Findings and implications. Journal of Telemedicine and Telecare 29: 390–398. https://doi.org/10.1177/1357633X20985763
- Marengoni A, Onder G (2015) Guidelines, polypharmacy, and drug-drug interactions in patients with multimorbidity. BMJ 350: h1059. https://doi.org/10.1136/bmj.h1059
- Meade LT, Tart RC, Buzby HL (2018) Evaluation of diabetes education and pharmacist interventions in a rural, primary care setting. Diabetes Spectrum 31: 90–95. https://doi.org/10.2337/ds16-0064
- Moore EC, Tolley CL, Bates DW, Slight SP (2020) A systematic review of the impact of health information technology on nurses' time. Journal of the American Medical Informatics Association 27: 798–807. https://doi.org/10.1093/jamia/ocz231
- Office for Health Improvement and Disparities (2020) Before-and-after study: comparative studies. GOV.UK. https://www.gov.uk/guidance/before-and-after-study-comparative-studies [September 30, 2023]
- Poudel A, Nissen L (2016) Telepharmacy: a pharmacist's perspective on the clinical benefits and challenges. Integrated Pharmacy Research and Practice Volume 5: 75–82. https://doi.org/10.2147/IPRP.S101685
- van Puijenbroek EP, Egberts ACG, Heerdink ER, Leufkens HGM (2000) Detecting drug-drug interactions using a database for spontaneous adverse drug reactions: an example with diuretics and non-steroidal anti-inflammatory drugs. European Journal of Clinical Pharmacology 56: 733–738. https://doi.org/10.1007/s002280000215
- Rasmussen OW, Lauszus F, Loekke M (2016) Telemedicine compared with standard care in type 2 diabetes mellitus: A randomized trial in an outpatient clinic. Journal of Telemedicine and Telecare 22: 363–368. https://doi.org/10.1177/1357633X15608984
- Rodríguez-Fortúnez P, Franch-Nadal J, Fornos-Pérez JA, Martínez-Martínez F, De Paz HD, Orera-Peña ML (2019) Cross-sectional study about the use of telemedicine for type 2 diabetes mellitus management in Spain: patients perspective. The EnREDa2 Study. BMJ Open 9: e028467. https://doi.org/10.1136/bmjopen-2018-028467
- Salamah S, Khafiyya AN, Ramadhani R, Arfiana MR, Syamsuri I, Faizah NN, Nugraha D, Arifin B, Alkaff FF (2023) Outcomes of the Indonesian Chronic Disease Management Program (PROLANIS) in Patients with Hypertension During the COVID-19 Pandemic in Rural Areas: A Preliminary Evaluation Study. Medical Science Monitor : International Medical Journal of Experimental and Clinical Research 29: e939797-1–e939797-9. https://doi.org/10.12659/MSM.939797
- Sheikh-Taha M, Asmar M (2021) Polypharmacy and severe potential drug-drug interactions among older adults with cardiovascular disease in the United States. BMC Geriatrics 21: 1–6. https://doi.org/10.1186/s12877-021-02183-0
- Smith M (2009) Pharmacists' role in improving diabetes medication management. Journal of diabetes science and technology 3: 175–179. https://doi.org/10.1177/193229680900300120
- Taha MB, Valero-Elizondo J, Yahya T, Caraballo C, Khera R, Patel KV, Ali HJR, Sharma G, Mossialos E, Cainzos-Achirica M, Nasir K (2022) Cost-related medication nonadherence in adults with diabetes in the United States: The National Health Interview Survey 2013–2018. Diabetes Care 45: 594–603. https://doi.org/10.2337/dc21-1757
- Tjiptoatmadja NN, Alfian SD (2022) Knowledge, perception, and willingness to use telepharmacy among the general population in Indonesia. Frontiers in Public Health 10: 1–6. https://doi.org/10.3389/fpubh.2022.825554
- WHO (2019) Medication Safety in Polypharmacy. https://www.who.int/publications/i/item/WHO-UHC-SDS-2019.11 [May 17, 2023]
- Zhang Z (2016) Model building strategy for logistic regression: purposeful selection. Annals of Translational Medicine 4: 1–7. https://doi.org/10.21037/atm.2016.02.15